Overview

A Study To Estimate How Much Tafamidis Created In Different Ways Can Be Measured in Blood Samples

Status:
Completed
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
All subjects in this study will be given tafamidis. After swallowing a single pill of tafamidis, measurements including blood samples will be compared to see if tafamidis made in different ways is about the same. After approximately 28 days subjects will be given another pill of tafamidis and the study measurements will be repeated.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer